Table 1 Baseline characteristics
Baseline characteristics (Total = 80,364) | DKA (n = 1,150) | Non-DKA (n = 2,413) | P-value |
|---|---|---|---|
Age; mean ± SD | 63 ± 12 | 64 ± 9 | 0.036 |
Female | 503 (43.73%) | 970 (40.24%) | 0.078 |
Hypertension | 582 (50.6%) | 1,002 (41.52%) | 0.044 |
Dyslipidemia | 485 (42.17%) | 1,187 (49.2%) | 0.012 |
Chronic lung disease | 177 (15.39%) | 380 (15.76%) | 0.956 |
Atrial fibrillation | 154 (13.39%) | 367 (15.22%) | 0.093 |
Anemia | 230 (20%) | 357 (14.81%) | 0.026 |
Congestive heart failure | 57 (4.95%) | 47 (1.95%) | 0.015 |
Cardiogenic shock | 219 (19.04%) | 232 (9.64%) | < 0.001 |
Peripheral vascular disease | 81 (7%) | 300 (12.44%) | 0.023 |
Prior stroke | 45 (3.91%) | 81 (3.37%) | 0.935 |
Chronic kidney disease | 207 (18%) | 461 (19.12%) | 0.682 |
Liver disease | 21 (1.8%) | 40 (1.65%) | 0.824 |
Smoking | 269 (23.39%) | 408 (16.91%) | 0.011 |
Drug abuse | 39 (3.39%) | 44 (1.84%) | 0.067 |
Coagulopathy | 94 (8.17%) | 81 (3.37%) | 0.025 |
Hyperthyroid | 119 (10.34%) | 88 (3.66%) | < 0.001 |
Treatment patterns | |||
Percutaneous coronary intervention | 65 (5.65%) | 106 (4.43%) | 0.237 |
IV thrombolysis | 437 (38%) | 1,032 (42.79%) | 0.034 |